Long read from Alexander Zaitchik writing for The New Republic: How Big Pharma Was Captured by the One Percent. It was published last year, but only now brought to my attention.

In truth, the pharmaceutical industry in the United States is largely socialized, especially upstream in the drug development process, when basic research cuts the first pathways to medical breakthroughs. Of the 210 medicines approved for market by the FDA between 2010 and 2016, every one originated in research conducted in government laboratories or in university labs funded in large part by the National Institutes of Health. Since 1938, the government has spent more than $1 trillion on biomedical research, and at least since the 1980s, a growing proportion of the primary beneficiaries have been industry executives and major shareholders. Between 2006 and 2015, these two groups received 99 percent of the profits, totaling more than $500 billion, generated by 18 of the largest drug companies. This is not a “business” functioning in some imaginary free market. It’s a system built by and for Wall Street, resting on a foundation of $33 billion in annual taxpayer-funded research.

We’ve been told that the American free market has brought us all of the wonders of modern medicine, but that’s a lie. Your tax dollars have funded these innovations, then the patents go to privately held companies that run up the cost, and the profit goes on to their shareholders. If you or your insurance can’t afford it: feel free to enjoy the American freedom to die.